Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

Biopharmaceutical company Crestone Pharmaceuticals last week announced positive topline results from a phase 2 trial of its investigational drug treatment for Clostridioides difficile infection (CDI).

Among the overarching trends is earlier and earlier treatment intensification to forestall development of metastases and castration-resistant prostate cancer (CRPC). Triplet therapy with docetaxel ...

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...

[43] Fewer treatment failures occurred with vancomycin use, but the difference was not significant. Relapse rates were also similar between treatment groups. Cost differences should be considered ...

They are more frequently found in girls than boys. Head lice live in all types of hair, whether it’s curly, straight, dyed or natural. Before you start treatment, understand how your child could have ...

Navigating type 2 diabetes treatment options can be complex, but finding the right approach is key. This guide will explore the various treatments available so you can make informed decisions and ...

By Lexy Perez Associate Editor Kate Middleton has shared that she has completed her chemotherapy treatment. In a video shared on Monday, the Princess of Wales shared that she is entering a “new ...